disposal of assets - 0.0% 174 0.3% (174) (100.0%) Other income(1) 3,419 6.4% 3,282 6.5% 137 4.2% Total revenue 53,444 100.0% 50,307 100.0% 3,137 6.2% Cost of sales of goods 34,980 65.5% 32,724 65.0% 2,257
hospital operations 8,880.5 8,073.3 807.2 10.0 Revenue from general patients 5,791.1 5,051.6 739.5 14.6 Revenue from Social Security patients 3,089.4 3,021.7 67.7 2.2 Cost of hospital operations (6,052.2
revenue 792 852 978 14.9% 23.5% Cost of sales 326 356 387 8.8% 19.0% Gross profit 466 496 591 19.2% 26.7% EBITDA 320 352 444 26.0% 38.8% Adjusted EBITDA1 324 361 451 25.1% 39.2% EBIT 236 251 333 32.5% 41.3
2015 Net sales 290.14 932.08 734.63 694.4 Other revenue 4.88 26.40 18.23 24.80 Total revenue 296.53 965.11 756.2 721.35 Cost of sales 109.12 389.64 330.05 309.05 Selling and administrative expenses
Criteria Land for constructing the plant 5.06 Appraisal by 3rd party appraisal company Water well 10 years rental 12.00 Design and exploration cost 5.00 Comparison done by the advisor to the project by price
. The preliminary features of JMART-W4 are shown in enclosure 3. 2.3 Any fraction of remaining Warrants shall be disregarded, in case, there are remaining Warrants from allocation, the Company will
. Cost of funds for 1Q19 remained stable at 2.3% comparing to 1Q18. For the three-month period ended Consolidated Change Mar 31, 2019 Mar 31, 2018 Baht million % Interest expense 1,386 1,143 242 21.2
for 3Q19 at 7.0% while cost of funds was at 2.4% resulting in loan spread for 3Q19 to decline to 4.6% from 5.1% during 3Q18. For the three-month period ended Consolidated Change Sept 30, 2019 Sept 30
เสี่ยงที่ยอมรับได้และเป้าหมายการลงทุนของลูกค้า (2) การก าหนดแผนจัดสรรการลงทุน (portfolio construction) การจัดสรรและก่าหนดสัดส่วนการลงทุน (“asset allocation”) ที่สอดคล้อง กับผลการประเมินระดับความเสี่ยงที่